Loading…
3 companies · GEL, thousands · columns ordered by revenue
Only 2 of 3 peers filed FY2024. Switch to FY2022 (3 of 3).
| Line item | Pardi Medikals | Lotusi | Shik Bebe |
|---|---|---|---|
| Total Revenue | 4,511 | 1,724 | — |
| Total COGS | -1,371 | -136 | — |
| Gross Profit | 3,141 | 1,587 | — |
| Gross Margin | 69.6% | 92.1% | — |
| Total Operating Expenses | -2,127 | -1,247 | — |
| EBITDA | 1,014 | 340 | — |
| EBITDA Margin | 22.5% | 19.7% | — |
| Total D&A | -11 | -95 | — |
| EBIT / Operating Income | 1,003 | 245 | — |
| Total Interest Income | 12 | — | — |
| Total Other Income | -13 | -218 | — |
| Profit Before Tax | 1,001 | 26 | — |
| Total Income Tax | 0 | 0 | — |
| Net Profit / (Loss) | 1,001 | 26 | — |
| Net Margin | 22.2% | 1.5% | — |
Not every picked company reports every selected year — FY2024: no filing for Shik Bebe. Those cells are left blank (no filing), not zero.
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Lotusi | Healthcare Services | 19.7% | 77th pct | 268 |
| Pardi Medikals | (unclassified) | 22.5% | 72nd pct | 1208 |
| Shik Bebe | FMCG | — | no FY data | 543 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.